Showing results (41-50 of 723) with videos related to

Sort By:
Pageof 73
Metabolism: Clinical and Experimental|September 11, 2021
Unravelling lipoprotein metabolism with stable isotopes: tracing the flowQidi Ying, Dick C Chan, P Hugh R Barrett, et al.
Current Opinion in Lipidology|November 7, 2024
A contemporary snapshot of familial hypercholesterolemia registriesSeyed Saeed Tamehri Zadeh, Jing Pang, Dick C Chan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2006
Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kineticsDick C Chan, Gerald F Watts, Minh N Nguyen, et al.
Frontiers in Cardiovascular Medicine|March 3, 2025
Deficient perceptions and practices concerning elevated lipoprotein(a) among specialists in SingaporeWann Jia Loh, Jing Pang, Oliver Simon, et al.
The American Journal of Clinical Nutrition|July 11, 2006
Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesityDick C Chan, Gerald F Watts, Minh N Nguyen, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2007
Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolismDick C Chan, Minh N Nguyen, Gerald F Watts, et al.
Pharmaceuticals (Basel, Switzerland)|November 24, 2022
Long-Term Efficacy and Safety of Evinacumab in Patients with Homozygous Familial Hypercholesterolemia: Real-World Clinical ExperienceClaudia Stefanutti, Dick C Chan, Serafina Di Giacomo, et al.
Atherosclerosis|August 11, 2016
Angiographic progression of coronary atherosclerosis in patients with familial hypercholesterolaemia treated with non-statin therapy: Impact of a fat-modified diet and a resinGerald F Watts, Jing Pang, Dick C Chan, et al.
European Journal of Clinical Investigation|March 16, 2022
Effect of a PCSK9 inhibitor and a statin on cholesterol efflux capacity: A limitation of current cholesterol-lowering treatments?Qidi Ying, Annalisa Ronca, Dick C Chan, et al.
Clinical Science (London, England : 1979)|May 22, 2009
Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndromeTheodore W K Ng, Dick C Chan, P Hugh R Barrett, et al.
Pageof 73